 - Received nephrotoxic drugs e.g., aminoglycosides, amphotericin B, vancomycin, cidofovir, foscarnet, cis-platinum, pentamidine etc. or competitors of renal excretion e.g., probenecid within 2 months prior to study screening or the expectation that patient will receive any of these during the course of the study. 